GeneDx Holdings Reports Q3 Revenue Beat Amid GAAP EPS Miss
GeneDx Holdings (WGS) reported third-quarter financial results characterized by a slight revenue beat and an earnings miss. The company posted revenue of $123.1 million, representing a 5.4% increase year-over-year, which marginally exceeded analyst expectations by $0.18 million. However, the company's GAAP earnings per share (EPS) came in at -$0.41, missing consensus estimates by $0.03. Following these results, management has updated its long-term 2026 guidance and provided new financial projections for the fourth quarter of 2026.
Tickers: $WGS
Topics: earnings miss guidance update revenue beat